IP Library Assignment 040913/0118
Patent Assignment
Reel/Frame 040913/0118

Security Agreement

Recorded: 2016-12-14 Pages: 7
Assignor
RELIABLE BIOPHARMACEUTICAL, LLC
Executed: 2016-12-13
Assignee
CITIBANK, N.A., AS COLLATERAL AGENT
580 CROSSPOINT PKWY, CRMS DOCUMENTATION UNIT, GETZVILLE, NEW YORK, 14068
Covered Properties (9)
Process for the Production of 2-Halo-6-Aminopurine Derivatives
Patent: 6,252,061 →
Application: 09/274,518 →
Process for the Production of 2-Halo-6-Aminopurine Derivatives
Patent: 6,596,858 →
Application: 09/803,765 →
Publication: US 2002/0052492
Process for the Production of Pentostatin Aglycone and Pentostatin
Patent: 7,393,954 →
Application: 10/734,545 →
Publication: US 2004/0181052
Process for Preparing Fondaparinux Sodium and Intermediates Useful in the Synthesis Thereof
Patent: 8,288,515 →
Application: 12/847,719 →
Publication: US 2011/0105418
Efficient and Scalable Process for the Manufacture of Fondaparinux Sodium
Patent: 8,420,790 →
Application: 12/915,864 →
Publication: US 2012/0116066
Process for Perparing Fondaparinux Sodium and Intermediates Useful in the Synthesis Thereof
Patent: 8,703,923 →
Application: 13/618,786 →
Publication: US 2013/0102764
Efficient and Scalable Process for the Manufacture of Fondaparinux Sodium
Patent: 8,987,430 →
Application: 13/791,178 →
Publication: US 2013/0261291
Processes for the Preparation of Regadenoson and a New Crystalline Form Thereof
Patent: 8,859,522 →
Application: 14/112,173 →
Publication: US 2014/0045781
Process for Perparing Fondaparinux Sodium and Intermediates Useful in the Synthesis Thereof
Patent: 9,255,119 →
Application: 14/256,235 →
Publication: US 2015/0018537
Related Assignments (8)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 1, 2013
From: WOOLDRIDGE, LUZVIMINDA T; MA, CHUN; NADJI, SOURENA
To: RELIABLE BIOPHARMACEUTICAL CORPORATION
Reel/Frame 031530/0463 →
Assignment of Assignor's Interest Oct 31, 2016
From: RELIABLE BIOPHARMACEUTICAL CORPORATION
To: RELIABLE BIOPHARMACEUTICAL, LLC
Reel/Frame 040174/0564 →
Assignment of Assignor's Interest Nov 10, 2016
From: RELIABLE BIOPHARMACEUTICAL CORPORATION
To: RELIABLE BIOPHARMACEUTICAL, LLC
Reel/Frame 040277/0548 →
Release (Reel 040913 / Frame 0118) Nov 27, 2017
From: CITIBANK, N.A.
To: RELIABLE BIOPHARMACEUTICAL, LLC
Reel/Frame 044511/0265 →
Security Agreement Nov 28, 2017
From: AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; APPLIED SILICONE COMPANY LLC; RELIABLE BIOPHARMACEUTICAL, LLC
To: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
Reel/Frame 044811/0400 →
Security Agreement Nov 29, 2017
From: AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; APPLIED SILICONE COMPANY LLC; RELIABLE BIOPHARMACEUTICAL, LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 044528/0960 →
Security Agreement (Notes) Nov 6, 2020
From: AVANTOR FLUID HANDLING, LLC; AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; RELIABLE BIOPHARMACEUTICAL, LLC
To: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 054343/0414 →
Termination and Release of Security Interest in Patents Nov 16, 2020
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
To: AVANTOR PERFORMANCE MATERIALS, LLC; NUSIL TECHNOLOGY LLC; APPLIED SILICONE COMPANY LLC; RELIABLE BIOPHARMACEUTICAL, LLC
Reel/Frame 054440/0877 →